高级搜索

性别对高、低发区食管癌患者生存期的影响

汤 萨, 黄 佳, 董金城, 袁 果, 李 燕, 张 朋, 宋 昕, 赵学科, 范宗民, 雷茜琳, 王立东

汤 萨, 黄 佳, 董金城, 袁 果, 李 燕, 张 朋, 宋 昕, 赵学科, 范宗民, 雷茜琳, 王立东. 性别对高、低发区食管癌患者生存期的影响[J]. 肿瘤防治研究, 2014, 41(03): 203-208. DOI: 10.3971/j.issn.1000-8578.2014.03.003
引用本文: 汤 萨, 黄 佳, 董金城, 袁 果, 李 燕, 张 朋, 宋 昕, 赵学科, 范宗民, 雷茜琳, 王立东. 性别对高、低发区食管癌患者生存期的影响[J]. 肿瘤防治研究, 2014, 41(03): 203-208. DOI: 10.3971/j.issn.1000-8578.2014.03.003
TANG Sa, HUANG Jia, DONG Jincheng, YUAN Guo, LI Yan, ZHANG Peng, SONG Xin, ZHAO Xueke, FAN Zongmin, LEI Xilin, WANG Lidong. Effects of Gender on Survival of Patients with Esophageal Cancer from High- and Lowincidence Areas[J]. Cancer Research on Prevention and Treatment, 2014, 41(03): 203-208. DOI: 10.3971/j.issn.1000-8578.2014.03.003
Citation: TANG Sa, HUANG Jia, DONG Jincheng, YUAN Guo, LI Yan, ZHANG Peng, SONG Xin, ZHAO Xueke, FAN Zongmin, LEI Xilin, WANG Lidong. Effects of Gender on Survival of Patients with Esophageal Cancer from High- and Lowincidence Areas[J]. Cancer Research on Prevention and Treatment, 2014, 41(03): 203-208. DOI: 10.3971/j.issn.1000-8578.2014.03.003

性别对高、低发区食管癌患者生存期的影响

基金项目: 国家科技部863重大资助项目(2012AA02A209,2012AA02A201)
详细信息
    作者简介:

    汤萨(1988-),女,硕士,主要从事食管和贲门癌变机制与防治研究

    通讯作者:

    王立东,E-mail: ldwang2007@126.com

  • 中图分类号: R735.1

Effects of Gender on Survival of Patients with Esophageal Cancer from High- and Lowincidence Areas

  • 摘要: 目的 加深对食管癌关键预后影响因素的了解。方法 通过入户或电话问卷调查及生存随访,采用卡方检验、Kaplan-Meier生存曲线和Log rank检验及Cox生存分析模型,分析1973—2011年间5 999 例女性和9 918例男性食管癌患者的生存差异及主要影响因素。结果 女性患者生存期显著高于男性(P=5.8E-25)。男性患者淋巴结转移率高于女性患者(P=2.7E-12),且T3、T4检出率明显高于女性患者,但是女性患者Tis、T1和T2检出率高于男性(P=1.2E-14);男、女性患者肿瘤分化程度相似(P=0.66)。 根据TNM分期进行早、中、晚期分类,女性早期癌患者比例高于男性(13.9% vs. 10.8%,P=3.8E-9),而中晚期患者的比例低于男性(86.1% vs. 89.2%,P=3.8E-9)。多因素Cox回归分析提示,女性为食管癌预后生存期长的保护因素,而淋巴结转移阳性和浸润程度(T)加深为危险因素。结论 女性患者生存期明显长于男性患者且为食管癌预后独立影响因素(保护因素);女性患者淋巴结转移和浸润程度(T3、T4)均低于男性检出率,是影响食管癌预后的独立危险因素。

     

    Abstract: Objective To further understand the key prognostic factors for esophageal cancer. Methods The questionnaire, home interview and / or telephone were performed for survival follow-up on esophageal cancer patients. The Chi-square test,Kaplan-Meier survival curve, Log rank test and multivariate Cox regression model were applied to assess the survival for the female (n=5 999) and male (n=9 918) esophageal cancer patients from 1973-2011. Results The survival time in female patients was signifi cantly higher than that in male (P=5.8E-25). It was noteworthy that, the rate of lymph node metastasis in male patients was higher than in female patients (P=2.7E-12).Furthermore, the prevalence of T3 and T4 in male patients was higher than that in female patients. In contrast, Tis, T1 and T2 in female patients was more common than that in male patients (P=1.2E-14). Interestingly, a similar degree of tumor differentiation was observed in male and female patients (P=0.66). Based on the TNM staging, the proportion of the patients with early stage in female was increased than that in male (13.9% vs.10.8%, P=3.8E-9).Accordingly, the proportion of middle and advanced stage in male was higher than that in female (86.1% vs.89.2%, P=3.8E-9).Cox regression analysis showed that female gender was protective factor, while with lymph node metastasis and invasion (T) deepening were risk factors for long survival of esophageal cancer. Conclusion The survival in female patients was signifi cantly longer than that in male patients. The rates of lymph node metastasis and invasion (T3, T4) in female were lower than those in male and independent factors for prognosis of esophageal cancer.

     

  • [1] Zou XN. Epidemiological characteristics of esophageal cancer [J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2006, 13(18): 1-4. [邹小农. 食管癌流行病学[J].中华肿瘤防治杂志,2006,13(18):1-4.]
    [2] Cook MB, Chow WH, Devesa SS.Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 [J]. Br J Cancer, 2009, 101(5):855-9.
    [3] Melhado RE,Alderson D,Tucker O.The changing face of esophageal cancer[J]. Cancers, 2010, 2(3), 1379-404.
    [4] Henan Medical College. Esophageal cancer[M]. Beijing, People’s Health Publishing House, 1983,36. [河南医学院. 食管癌[M]. 北 京:人民卫生出版社,1983,36.]
    [5] Bohanes P,Yang D,Chhibar RS,et al.Infl uence of sex on the survival of patients with esophageal cancer[J].J Clin Oncol,2012,30 (18) :2265-72.
    [6] Wang QM,Qi YJ,Jiang Q,et al.Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China[J].Med Oncol,2011, 28 (1):188-93.
    [7] Bodelon C,Anderson GL,Rossing MA,et al.Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women[J]. Cancer Prev Res (Phila),2011,4 (6) :840-50.
    [8] Matsuoka H, Sugimachi K, Ueo H,et al.Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma[J]. Cancer Res,1987,47 (15):4134-40.
    [9] Wang QM,Ma ZY,Zhu H,et al.Association of age distribution of esophageal squamous cell carcinoma with expressed alterations of sex hormone receptors[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 20 08, 15(17): 1308-11. [王启鸣,马智勇,朱辉,等. 食管鳞癌 的年龄分布与性激素受体表达变化的相关研究[J].中华肿瘤防 治杂志,2008,15(17):1308- 11.]
    [10] Ueo H,Matsuoka H,Sugimachi K,et al.Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line[J]. Cancer Res, 1990, 50(22):7212-5.
    [11] Zuguchi M,Miki Y,Onodera Y,et al.Estrogen receptor α and β in esophageal squamous cell carcinoma[J].Cancer Sci,2012,103 (7) :1348-55.
    [12] Kalayarasan R,Ananthakrishnan N,Kate V,et al.Estrogen and progesterone receptors in esophageal carcinoma[J].Dis Esophagus,2008,21 (4):298-303.
    [13] Nozoe T,Oyama T,Takenoyama M,et al.Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus[J].Clin Cancer Res,2007, 13 (14):4046-50.
    [14] Ishizuka S,Satou S.A case of delivery of healthy infant in breast cancer patient incidentally treated with goserelin acetate and tamoxifen during pregnancy[J]. Breast Cancer,2013,[Epub ahead of print].
    [15] Yamazawa K,Hirai M,Fujito A,et al.Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer[J].Hum Reprod,2007,22 (7) :1953-8.
    [16] Cunha S,Gano L,Morais GR,et al.Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy[J].J Steroid Biochem Mol Biol, 20 13,137:223-41.
    [17] Fei AX,Xiao XL,You AP,et al.Sex hormone level change of perimenopausal women[J]. Zhongguo Fu You Bao Jian, 2003, 18 (7) : 406-7. [费安兴,肖新立,游爱平,等.围绝经期妇女性激素水 平的变化[J]. 中国妇幼保健,2003,18(7):406-7.]
    [18] Wang LD,Song X.Interaction of environmental and hereditary factors on human esophageal carcinogenesis[J]. Zhengzhou Da Xue Xue Bao(Yi Xue Bao), 2011,46 (1):1-4.[王立东, 宋昕. 环境 和遗传因素交互作用对食管癌发生的影响[J].郑州大学学报 (医学版) ,2011,46(1):1-4.]
    [19] Croce J,de Carvalho Filho ET,Pasini U,et al.The evaluation of cellular immunity in the aged by skin tests[J].Allergol Immunopathol (Madr), 1984,12(2):105-9.
    [20] Yamashita Y,Hirai T,Mukaida H,et al.Detection of androgen receptors in human esophageal cancer[J].Jpn J Surg,1989,19 (2) :195-202.
    [21] Hawk E,Breslow RA,Graubard BI.Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the fi rst National Health and Nutrition Examination Survey[J].Cancer Epidemiol Biomarkers Prev, 2000, 9 (5):523-7.
    [22] Wright JL,Page ST,Lin DW,et al.Male pattern baldness and prostate cancer risk in a population-based case-control study[J]. Cancer Epidemiol,2010, 34 (2):131-5.
计量
  • 文章访问数:  1238
  • HTML全文浏览量:  331
  • PDF下载量:  1039
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-06-02
  • 修回日期:  2013-09-04
  • 刊出日期:  2014-03-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭